Actinium Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 266,000. Operating loss was USD 5.075 million compared to USD 4.662 million a year ago. Net loss was USD 5.021 million compared to USD 4.625 million a year ago. Basic loss per share from continuing operations was USD 0.25 compared to USD 0.41 a year ago. For the half year, total revenue was USD 888,000. Operating loss was USD 10.447 million compared to USD 10.345 million a year ago. Net loss was USD 10.341 million compared to USD 10.295 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 1.2 a year ago.